Ondine Biomedical (UK) Top Management

Ondine Biomedical Management Team Effectiveness

The company has return on total asset (ROA) of (1.5971) % which means that it has lost $1.5971 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (6.8559) %, meaning that it generated substantial loss on money invested by shareholders. Ondine Biomedical's management efficiency ratios could be used to measure how well Ondine Biomedical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Ondine Biomedical's Non Current Assets Total are projected to decrease significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 7.7 M, whereas Non Currrent Assets Other are forecasted to decline to about 33.2 K. As of November 28, 2024, Common Stock Shares Outstanding is expected to decline to about 101.2 M. The current year's Net Loss is expected to grow to about (42.8 M)

Ondine Biomedical Workforce Comparison

Ondine Biomedical Benchmark Summation

Ondine Biomedical Notable Stakeholders

The success or failure of an entity such as Ondine Biomedical often depends on how effective the management is. Ondine Biomedical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Ondine management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Ondine management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Ondine Biomedical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ondine Biomedical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Ondine Biomedical's management manipulating its earnings.

When running Ondine Biomedical's price analysis, check to measure Ondine Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ondine Biomedical is operating at the current time. Most of Ondine Biomedical's value examination focuses on studying past and present price action to predict the probability of Ondine Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ondine Biomedical's price. Additionally, you may evaluate how the addition of Ondine Biomedical to your portfolios can decrease your overall portfolio volatility.